To provide a pharmaceutical composition for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction.SOLUTION: Disclosed is the use of linagliptin for preparation of a pharmaceutical composition for use in a method of treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction, including the step of administering linagliptin.SELECTED DRAWING: None